NCT07406893 Reduction of Bacterial Seeding in Total Shoulder Arthroplasty
| NCT ID | NCT07406893 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Louis University |
| Condition | Joint Arthroplasty |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-02-23 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-02-23 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to compare the growth of intra-operative tissue cultures of Cutibacterium Acnes after primary shoulder replacement when using a no-prep control group versus Prontosan wound gel applied to the skin layer after the skin incision has been made.
Eligibility Criteria
Inclusion Criteria: * Adult male 18 years of age or older undergoing elective primary total shoulder arthroplasty, including both anatomic and reverse total shoulder arthroplasty, for indications including massive rotator cuffs, rotator cuff arthropathy, glenohumeral osteoarthritis, and acute fractures. Exclusion Criteria: * Any revision shoulder arthroplasty procedure or other shoulder surgery that is not a primary shoulder arthroplasty. * Patients with allergy to active ingredients in Prontosan gel * Patient is unable to consent for themselves * Patient is non-English speaking * Females
Contact & Investigator
Randall Otto, MD
PRINCIPAL INVESTIGATOR
St. Louis University
Frequently Asked Questions
Who can join the NCT07406893 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Joint Arthroplasty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07406893 currently recruiting?
Yes, NCT07406893 is actively recruiting participants. Contact the research team at randy.otto@health.slu.edu for enrollment information.
Where is the NCT07406893 trial being conducted?
This trial is being conducted at St Louis, United States.
Who is sponsoring the NCT07406893 clinical trial?
NCT07406893 is sponsored by St. Louis University. The principal investigator is Randall Otto, MD at St. Louis University. The trial plans to enroll 60 participants.